Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Employer
- The University of Arizona
- Nature Careers
- THE UNIVERSITY OF HONG KONG
- University of North Carolina at Chapel Hill
- Baylor College of Medicine
- Stanford University
- Aarhus University
- Argonne
- Forschungszentrum Jülich
- ICN2
- KINGS COLLEGE LONDON
- Technical University of Denmark
- University of Oslo
- University of Oxford
- University of Utah
- Angelo State University
- Cornell University
- Fred Hutchinson Cancer Center
- INSERM
- Kiel University;
- MOHAMMED VI POLYTECHNIC UNIVERSITY
- NEW YORK UNIVERSITY ABU DHABI
- National Hellenic Research Foundation
- University of Basel
- University of Southern Denmark
- Washington State University
- BENAJIBA team - INSERM U1342 - Saint-Louis Research Institute
- Central State University
- Delft University of Technology (TU Delft); yesterday published
- ETH Zürich
- Eindhoven University of Technology (TU/e)
- Eindhoven University of Technology (TU/e); yesterday published
- Florida International University
- GSI Helmholtzzentrum für Schwerionenforschung
- Gustave Roussy Cancer Campus
- ICFO - The Institute of Photonic Sciences
- Institut Pasteur
- KU LEUVEN
- Medical College of Wisconsin
- Missouri University of Science and Technology
- New York University
- Northeastern University
- Radboud University Medical Center (Radboudumc)
- Texas A&M AgriLife
- The Ohio State University
- The University of North Carolina at Chapel Hill
- UNIVERSITY OF SYDNEY
- Universidade de Coimbra
- University of Amsterdam (UvA)
- University of Amsterdam (UvA); Published today
- University of Amsterdam (UvA); yesterday published
- University of Colorado
- University of Dundee;
- University of Florida
- University of Lille
- University of Lund
- University of Luxembourg
- University of Massachusetts Boston
- University of Miami
- University of Minnesota
- University of Oxford;
- University of Salzburg
- University of Southern California
- University of Southern California (USC)
- University of Sydney
- University of Texas at Dallas
- University of Tübingen
- University of Virginia
- University of Washington
- Université de Bordeaux / University of Bordeaux
- Uppsala universitet
- Wayne State University
- Łukasiewicz Research Network - Krakow Institute of Technology
- 63 more »
- « less
-
Field
-
Institute to address therapeutic targets which can be brought to the patient bedside. One Postdoctoral Fellow position is available in the Zhu lab. Our team is looking to add a motivated, ambitious, and
-
strategies, with specific targets established to track progress. The Fellow is expected to demonstrate the potential to contribute meaningfully to disability employment scholarship, collaborative team research
-
personal and team-work skills. Priority will be given to applicants with strong and proven track record in NMR-based structural biology. Who we are The Interdisciplinary Nanoscience Center (iNANO
-
applications for postdoctoral fellowships in formal methods and programming languages, with emphasis on theorem proving. The positions can have a duration of up to 4 years. The targeted starting period is after
-
Hutch is the only National Cancer Institute-designated cancer center in Washington. With a track record of global leadership in bone marrow transplantation, HIV/AIDS prevention, immunotherapy and COVID-19
-
-institutional, interdisciplinary effort to deconvolve the roles of chromatin-modifying enzymes in genome-wide gene regulation. These enzymes represent emerging drug targets in pediatric solid tumors and
-
, applicants with a strong track record of publications in high-quality international journals are especially encouraged to apply. The candidate will contribute to one of the following projects: 1. Using mass
-
to translate findings from your models to interventions with our target groups; You will be a kind, constructive, and reliable participant in regular consortium meetings; You will explain your mathematical
-
, interdisciplinary environment, and contributing to the TARGET-SEC project's overarching goal of identifying novel therapeutic strategies targeting pro-tumorigenic stroma-epithelial interactions in CRC. The person
-
involves the development and optimization of both in vitro and in vivo models to investigate diabetes-related disease mechanisms and to evaluate potential therapeutic targets. Working under the supervision